Littlejohn Financial Services Inc. Invests $245,000 in Humana Inc. $HUM

Key Points

• Littlejohn Financial Services Inc. recently invested approximately $245,000 in Humana Inc., acquiring 1,004 shares of the insurance provider's stock.
• Institutional investors hold a substantial 92.38% of Humana's shares, with numerous firms adjusting their stakes in the company throughout the year.
• Humana has announced a quarterly dividend of $0.885 per share, which will be paid to stockholders on October 31st, representing an annualized yield of 1.4%.

Littlejohn Financial Services Inc. bought a new position in Humana Inc. (NYSE:HUM - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 1,004 shares of the insurance provider's stock, valued at approximately $245,000.

Several other large investors have also added to or reduced their stakes in the stock. Cary Street Partners Investment Advisory LLC raised its holdings in shares of Humana by 63.9% in the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after acquiring an additional 46 shares in the last quarter. Riverview Trust Co purchased a new position in Humana in the 1st quarter worth approximately $34,000. Garde Capital Inc. purchased a new position in Humana in the 1st quarter worth approximately $36,000. Zions Bancorporation National Association UT purchased a new position in Humana in the 1st quarter worth approximately $37,000. Finally, Whipplewood Advisors LLC increased its stake in Humana by 639.1% in the 1st quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock worth $45,000 after purchasing an additional 147 shares during the period. Institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Wells Fargo & Company cut their price objective on Humana from $348.00 to $344.00 and set an "overweight" rating on the stock in a research report on Thursday, August 14th. Truist Financial lowered their price objective on Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Evercore ISI began coverage on Humana in a research note on Monday. They set an "in-line" rating and a $295.00 price objective for the company. Sanford C. Bernstein lifted their price objective on Humana from $269.00 to $341.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Finally, Royal Bank Of Canada boosted their price target on Humana from $283.00 to $322.00 and gave the stock an "outperform" rating in a research note on Thursday, August 21st. Seven research analysts have rated the stock with a Buy rating and seventeen have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $289.50.

Humana Stock Performance

NYSE:HUM opened at $262.14 on Thursday. The stock has a 50-day simple moving average of $270.61 and a two-hundred day simple moving average of $257.26. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $324.38. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. The firm has a market capitalization of $31.53 billion, a PE ratio of 20.12, a P/E/G ratio of 1.52 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same period in the prior year, the firm posted $6.96 EPS. The business's revenue for the quarter was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. Analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. Humana's dividend payout ratio is 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.